Investing.com - Avita Medical (NASDAQ:RCEL) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Avita Medical announced earnings per share of $-0.26 on revenue of $8.76M. Analysts polled by Investing.com anticipated EPS of $-0.3501 on revenue of $7.33M.
Avita Medical shares are up 7.16% from the beginning of the year, still down 42.95% from its 52 week high of $34.90 set on June 5, 2020. They are outperforming the Nasdaq which is up 1.84% from the start of the year.
Avita Medical follows other major Healthcare sector earnings this month
Avita Medical's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Pfizer had beat expectations on May 4 with first quarter EPS of $0.93 on revenue of $14.58B, compared to forecast for EPS of $0.7759 on revenue of $13.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar